SCHEMBL17486272

SCHEMBL17486272

CC1(C)Oc2ccc(-c3ccc(Br)cn3)cc2O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.40
TSHR P16473 1/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CA2 P00918 1/20 0.35
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
S1PR1 P21453 1/20 0.32
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
GPR55 Q9Y2T6 1/20 0.31
PGR P06401 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20805726 0.83 CCR1 (0.46) KIF11TSHRNPC1RAB9ANFKB1
SCHEMBL17486268 0.81 BACE1 (0.36) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL17486160 0.76 DGAT1 (0.51) KIF11TSHRSNCADGAT1
SCHEMBL361525 0.74 TSHR (0.56) KIF11TSHRNPC1RAB9ASMN1; SMN2
SCHEMBL29457677 0.74 TSHR (0.56) KIF11TSHRNPC1RAB9ASMN1; SMN2
SCHEMBL17486216 0.74 MAPK1 (0.37) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL17477823 0.72 NPC1 (0.38) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL19933574 0.72 NPC1 (0.52) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL20007152 0.71 NPC1 (0.37) NPC1RAB9ASMN1; SMN2NFKB1MAPK1
SCHEMBL18015415 0.71 NPC1 (0.37) NPC1RAB9ASMN1; SMN2NFKB1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 KIF11 1798/4885TSHR 4496/4885NPC1 3516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.